About Rexit Pharmaceutical
Rexit Pharmaceutical is a Healthcare company based in Chandigarh (India) founded in 2017. Wholesaler and trader of pharmaceutical tablets, capsules, syrups, and injections. It operates on a B2B and Wholesale Distribution model. Its Indian entity Rexit Pharmaceutical Private Limited reported revenue of ₹2.76 Cr. Rexit Pharmaceutical offers products and services including Tablets and Capsules, Syrups, Injectables, and Paediatric Section. Its focus areas include Pharmaceuticals, Drugs and Medicines, Syrups and Injectables and Tablets and Capsules. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Rexit Pharmaceutical Private Limited operates as a wholesaler and distributor of various pharmaceutical products, including tablets, capsules, syrups, injectables, and paediatric medicines. The company sources and supplies these items to businesses, focusing on quality and compliance with health standards. Based in Sas Nagar, Punjab, India, it serves the pharmaceutical market through a range of categories like cardio, diabetic, and ayurvedic products. Its activities involve trading and distributing medicines for clinical and commercial use.
- Headquarters Chandigarh, India
- SectorsHealthcare
- Phone•••• ••••
- Website rexitpharma.com
- Legal Name Rexit Pharmaceutical Private Limited
- Date of Incorporation 14 Feb, 2017
- Jurisdiction Patiala, Punjab, India
- Annual Revenue₹2.76 Cr
FY 2024 · +7% YoY
- Net Profit₹3.6 Lakh
FY 2024 · 1% margin
- EBITDA₹6.8 Lakh
FY 2024 · 2% margin
Associated legal entities of Rexit Pharmaceutical
Rexit Pharmaceutical operates through Rexit Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rexit Pharmaceutical Private Limited CIN U51909PB2017PTC046135 | Active | 14 Feb 2017 | Patiala, Punjab | ₹2.8 Cr | 2 | View details |
Products & Services of Rexit Pharmaceutical
Rexit Pharmaceutical offers a comprehensive portfolio of products and services, including Tablets and Capsules, Syrups, Injectables, and Paediatric Section.
Medicines for various health conditions like allergies and pain relief.
Syrups for cough, digestion, and paediatric use.
Injections for antibiotic treatment and infections.
Syrups and suspensions for children's fever and pain.
Board of directors of Rexit Pharmaceutical Private Limited (Rexit Pharmaceutical)
Rexit Pharmaceutical Private Limited is the primary company behind Rexit Pharmaceutical. The board of Rexit Pharmaceutical Private Limited currently have 2 directors; the longest-serving is Nimka Rani, appointed in 2017. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nimka Rani DIN 07711369 | Director | 14 Feb 2017 | 9 yrs 8 mo | Rexit Pharmaceutical Private Limited |
| Rakesh Kumar DIN 10482648 | Director | 30 Jan 2024 | 2 yrs 9 mo | Rexit Pharmaceutical Private Limited |
Financials of Rexit Pharmaceutical
Figures of Rexit Pharmaceutical Private Limited, the primary company behind Rexit Pharmaceutical, for FY 2024. Revenue was ₹2.76 Cr (+7% year on year). Net profit was ₹3.6 Lakh (1% margin). EBITDA was ₹6.8 Lakh (2% margin). Revenue has grown at a compounded annual rate of +15% over three years and +24% over five years.
- ₹2.76 CrRevenue · FY 2024 · +7% YoY
- ₹3.6 LakhNet profit · 1% margin
- ₹6.8 LakhEBITDA · 2% margin
- ₹1 LakhPaid-up capital
- +15%Revenue CAGR, 3 years
- +24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Rexit Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Rexit Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Rexit Pharmaceutical
Rexit Pharmaceutical has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Rexit Pharmaceutical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rexit Pharmaceutical
Rexit Pharmaceutical was founded in 2017.
Rexit Pharmaceutical is headquartered in Chandigarh, India.
The primary company behind Rexit Pharmaceutical, Rexit Pharmaceutical Private Limited, reported revenue of ₹2.76 Cr for FY 2024, up 7% year on year.
Rexit Pharmaceutical Private Limited operates as a wholesaler and distributor of various pharmaceutical products, including tablets, capsules, syrups, injectables, and paediatric medicines. The company sources and supplies these items to businesses, focusing on quality and compliance with health standards. Based in Sas Nagar, Punjab, India, it serves the pharmaceutical market through a range of categories like cardio, diabetic, and ayurvedic products. Its activities involve trading and distributing medicines for clinical and commercial use.
Rexit Pharmaceutical's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Rexit Pharmaceutical offers Tablets and Capsules, Syrups, Injectables, and Paediatric Section.
Rexit Pharmaceutical operates through Rexit Pharmaceutical Private Limited.
The legal entities of Rexit Pharmaceutical currently have 2 directors, including Nimka Rani, Rakesh Kumar.